Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis

作者: S Stelloo , E Nevedomskaya , Y Kim , L Hoekman , O B Bleijerveld

DOI: 10.1038/ONC.2017.330

关键词:

摘要: Androgen receptor (AR) is a key player in prostate cancer development and progression. Here we applied immunoprecipitation mass spectrometry of endogenous AR LNCaP cells to identify components the transcriptional complex. In total, 66 known novel interactors were identified presence synthetic androgen, most which critical for AR-driven cell proliferation. A subset required proliferation profiled using chromatin assays followed by sequencing, identifying distinct genomic subcomplexes interaction partners. Interestingly, three major subgroups identified, where selective gain function action tumorigenesis was found, dictated FOXA1 HOXB13. summary, combining proteomic approaches reveal subclasses complexes, differentiating normal behavior from oncogenic state. this process, expression has roles reprogramming cistrome interactome location-specific manner.

参考文章(58)
L. Spans, D. Vanderschueren, L. Clinckemalie, E. Lerut, F. Claessens, C. Helsen, V. Dubois, S. Boonen, N. Van Tilborgh, The transcription intermediary factor 1β coactivates the androgen receptor Journal of Endocrinological Investigation. ,vol. 36, pp. 699- 706 ,(2013) , 10.3275/8927
G. J. Van Steenbrugge, W. M. Van Weerden, C. M. A. De Ridder, J. C. Romijn, C. L. Verdaasdonk, F. H. Schröder, T. H. Van Der Kwast, Development of seven new human prostate tumor xenograft models and their histopathological characterization. American Journal of Pathology. ,vol. 149, pp. 1055- 1062 ,(1996)
B. Le Douarin, A. L. Nielsen, J. M. Garnier, H. Ichinose, F. Jeanmougin, R. Losson, P. Chambon, A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. The EMBO Journal. ,vol. 15, pp. 6701- 6715 ,(1996) , 10.1002/J.1460-2075.1996.TB01060.X
Toshiki Etani, Takayoshi Suzuki, Taku Naiki, Aya Naiki-Ito, Ryosuke Ando, Keitaro Iida, Noriyasu Kawai, Keiichi Tozawa, Naoki Miyata, Kenjiro Kohri, Satoru Takahashi, NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect Oncotarget. ,vol. 6, pp. 2865- 2878 ,(2015) , 10.18632/ONCOTARGET.3067
Mark M Pomerantz, Fugen Li, David Y Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vazquez, Jennifer Cook, Ramesh A Shivdasani, Michaela Bowden, Rosina Lis, William C Hahn, Philip W Kantoff, Myles Brown, Massimo Loda, Henry W Long, Matthew L Freedman, The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis Nature Genetics. ,vol. 47, pp. 1346- 1351 ,(2015) , 10.1038/NG.3419
Rohini Jasavala, Harryl Martinez, Jaykumar Thumar, Armann Andaya, Anne-Claude Gingras, Jimmy K. Eng, Ruedi Aebersold, David K. Han, Michael E. Wright, Identification of Putative Androgen Receptor Interaction Protein Modules Cytoskeleton and Endosomes Modulate Androgen Receptor Signaling in Prostate Cancer Cells Molecular & Cellular Proteomics. ,vol. 6, pp. 252- 271 ,(2007) , 10.1074/MCP.M600169-MCP200
Zhi‐Qing Huang, Jiwen Li, Laurent M Sachs, Philip A Cole, Jiemin Wong, A role for cofactor–cofactor and cofactor–histone interactions in targeting p300, SWI/SNF and Mediator for transcription The EMBO Journal. ,vol. 22, pp. 2146- 2155 ,(2003) , 10.1093/EMBOJ/CDG219
Yeqing Angela Yang, Jindan Yu, Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer. Genes and Diseases. ,vol. 2, pp. 144- 151 ,(2015) , 10.1016/J.GENDIS.2015.01.003